Legend Biotech CFO to resign

Reuters

2024-12-24

Dec 23 (Reuters) - Cancer therapy maker Legend Biotech's

Chief Financial Officer Lori Macomber has submitted her resignation notice to the company, a filing with the U.S. Securities and Exchange Commission showed on Monday.

Macomber, who was promoted to the CFO role in 2022, would step down due to personal reasons, effective Jan. 2, 2025, the filing added.

Insider Jessie Yeung has been appointed as the interim CFO and the board has designated her as company's interim principal financial officer.

(Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Mohammed Safi Shamsi)

((AnujaBharat.Mistry@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2493719586"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2493719586\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2493719586?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-24 06:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2493719586","market":"us","top_or_hot":-1,"title":"Legend Biotech CFO to resign","media":"Reuters","content":"<html><body><p>Dec 23 (Reuters) - Cancer therapy maker Legend Biotech's</p><p>  Chief Financial Officer Lori Macomber has submitted her resignation notice to the company, a filing with the U.S. Securities and Exchange Commission showed on Monday.</p><p>   Macomber, who was promoted to the CFO role in 2022, would step down due to personal reasons, effective Jan. 2, 2025, the filing added.</p><p>   Insider Jessie Yeung has been appointed as the interim CFO and the board has designated her as company's interim principal financial officer. </p><p> (Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Mohammed Safi Shamsi)</p><p>((AnujaBharat.Mistry@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Legend Biotech CFO to resign</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLegend Biotech CFO to resign\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-12-24 06:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Dec 23 (Reuters) - Cancer therapy maker Legend Biotech's</p><p>  Chief Financial Officer Lori Macomber has submitted her resignation notice to the company, a filing with the U.S. Securities and Exchange Commission showed on Monday.</p><p>   Macomber, who was promoted to the CFO role in 2022, would step down due to personal reasons, effective Jan. 2, 2025, the filing added.</p><p>   Insider Jessie Yeung has been appointed as the interim CFO and the board has designated her as company's interim principal financial officer. </p><p> (Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Mohammed Safi Shamsi)</p><p>((AnujaBharat.Mistry@thomsonreuters.com;))</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4505","symbol_name":"高瓴资本持仓","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2493719586","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493719586","pubTimestamp":1734991347,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Dec 23  - Cancer therapy maker Legend Biotech's  Chief Financial Officer Lori Macomber has submitted her resignation notice to the company, a filing with the U.S. Securities and Exchange Commission showed on Monday.   Macomber, who was promoted to the CFO role in 2022, would step down due to personal reasons, effective Jan. 2, 2025, the filing added.   Insider Jessie Yeung has been appointed as the interim CFO and the board has designated her as company's interim principal financial officer.  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4505":"高瓴资本持仓","BK4139":"生物科技","LEGN":"传奇生物","BK4585":"ETF&股票定投概念","BK4588":"碎股"},"translate_title":"传奇生物首席财务官辞职","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LEGN":1},"content_text":"Dec 23 (Reuters) - Cancer therapy maker Legend Biotech's  Chief Financial Officer Lori Macomber has submitted her resignation notice to the company, a filing with the U.S. Securities and Exchange Commission showed on Monday.   Macomber, who was promoted to the CFO role in 2022, would step down due to personal reasons, effective Jan. 2, 2025, the filing added.   Insider Jessie Yeung has been appointed as the interim CFO and the board has designated her as company's interim principal financial officer.  (Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Mohammed Safi Shamsi)((AnujaBharat.Mistry@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1}}}